The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer Michael SofopoulosSotirios P. FortisConstantin N. Baxevanis Original Article 09 October 2019 Pages: 1733 - 1745
Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy Donastas Sakellariou-ThompsonMarie-Andrée ForgetChantale Bernatchez Original Article 10 October 2019 Pages: 1747 - 1757
Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer A. Marijne HeerenIske F. van LuijkEkaterina S. Jordanova Original Article Open access 15 October 2019 Pages: 1759 - 1767
Contribution of Fcγ receptor IIB to creating a suppressive tumor microenvironment in a mouse model Yuki KasaharaHidekazu ShirotaChikashi Ishioka Original Article 15 October 2019 Pages: 1769 - 1778
Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer Yujun ParkJiwon KohHye Seung Lee Original Article 16 October 2019 Pages: 1779 - 1790
Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine Caterina LapentaSimona DonatiStefano M. Santini Original Article 16 October 2019 Pages: 1791 - 1804
Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation Anthony L. SchwartzPulak R. NathDavid D. Roberts Original Article 18 October 2019 Pages: 1805 - 1817
Schwann cells shape the neuro-immune environs and control cancer progression German V. MartynGalina V. ShurinMichael R. Shurin Focussed Research Review 03 January 2019 Pages: 1819 - 1829
The challenges of adoptive cell transfer in the treatment of human renal cell carcinoma Zuzana StrizovaJirina BartunkovaDaniel Smrz Focussed Research Review 20 June 2019 Pages: 1831 - 1838
Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy Lidia TaroneGiuseppina BarutelloFederica Riccardo Focussed Research Review 20 June 2019 Pages: 1839 - 1853
Adhering to adhesion: assessing integrin conformation to monitor T cells Cécile GouttefangeasJuliane SchuhmacherStoyan Dimitrov Focussed Research Review 15 July 2019 Pages: 1855 - 1863
CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models Bjarne BogenMarte FauskangerAnders Tveita Focussed Research Review 26 August 2019 Pages: 1865 - 1873
Activation of dendritic cells by targeted DNA: a potential addition to the armamentarium for anti-cancer immunotherapy Marlene Fyrstenberg LaursenEmil Kofod-OlsenRalf Agger Focussed Research Review 26 September 2019 Pages: 1875 - 1880
Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy Timothy T. SpearBrian D. EvavoldMichael I. Nishimura Focussed Research Review 08 October 2019 Pages: 1881 - 1889
Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation Julia K. Bialek-WaldmannMichael HeuserRenata Stripecke Focussed Research Review Open access 18 October 2019 Pages: 1891 - 1899
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope Evelina MartinenaiteShamaila Munir AhmadMads Hald Andersen Focussed Research Review 06 November 2019 Pages: 1901 - 1907